University of California San Francisco

Monika Sarkar, MD, MAS

Monika Sarkar MD MAS
Monika
Sarkar
MD, MAS

Associate Professor 
Department of Medicine
Division of Gastroenterology and Hepatology

Address

513 Parnassus Avenue MSB, #357F
San Francisco, CA 94143
United States

ORCID: 0000-0003-4233-1062

Biography

My clinical focus is on women with liver disease, including pregnancy-related liver conditions and reproductive health. My research program is focused on the role of sex hormones in modulating liver disease in women. I have a specific research interest in young women with the hyperandrogenic condition known as Polycystic Ovarian Syndrome given their high risk for developing Non Alcoholic Fatty Liver Disease (NAFLD) and early onset liver scarring. Within the transplant setting my focus is reproductive health, including pregnancy and contraceptive management in transplant recipients.

Education

Institution Degree Dept or School End Date
UCSF Transplant Hepatology Fellowship 2013
UCSF Gastroenterology Fellowship 2012
UCSF M.A.S. in Clinical Research Graduate Division (Advance Training in Clinical Research) 2012
University of Pennsylvania Internal Medicine Residency 2009
UCSF M.D. School of Medicine 2006
Vassar College BA 2002

Board Certifications

American Board of Internal Medicine
American Board of Internal Medicine - Gastroenterology
American Board of Internal Medicine - Transplant Hepatology

Awards & Honors

Award Conferred By Date
R03 NIDDK 2022/2024
K23 NIDDK 2017/2023
K Scholars Team Science Award UCSF 2017/2018
UCSF Hellman Research Award UCSF 2016/2018
RAP Pilot Award for Junior Investigators UCSF 2016/2017
Liver Center Flex Funds UCSF 2015/2016
Liver Center Pilot/Feasibility Research Award UCSF Liver Center 2014/2015
Sheila Sherlock Career Development Research Award AASLD 2013/2015
Advanced Hepatology Fellowship Award AASLD 2012/2013

Clinical Expertise

Alcoholic Liver Disease
Autoimmune Hepatitis
Cirrhosis
Drug-Induced Hepatitis
Fulminant Hepatic Failure
Hemochromatosis
Hepatitis B
Hepatitis C
Hepatocellular Carcinoma (Liver Cancer)
Liver Transplantation
Living Donor Liver Transplantation
Nonalcoholic Fatty Liver Disease
Polycystic Liver Disease
Primary Biliary Cirrhosis
Primary Sclerosing Cholangitis

Clinical Trials

  1. Bicalutamide Therapy in Young Women With NAFLD and PCOS (NCT05979389)
    Related Conditions: Nonalcoholic Fatty Liver Disease, Polycystic Ovary Syndrome, Liver Disease| Start Date: | End Date:
  2. Spironolactone Therapy In Young Women With NASH (NCT03576755)
    Related Conditions: Nonalcoholic Steatohepatitis, Steatohepatitis, Liver Disease, Nonalcoholic Fatty Liver Disease| Start Date: | End Date:

Program Affiliations

UCSF Liver Center

Grants and Funding

  • Influence of Androgens on Tissue-Specific Lipid Metabolites and Liver Injury in Young Women with NAFLD | NIDDK | 2022-03-15 - 2024-03-15 | Role: Principle Investigator
  • Androgens and Nonalcoholic Steatohepatitis: The Role of Male Sex Hormones in Women with NASH | NIH | 2017-07-10 - 2023-06-30 | Role: Principal Investigator

Research Narrative

My research program is focused on the role of sex hormones on liver injury in women, including the effects of reproductive aging, pregnancy, and androgens. I have a specific interest in young women with the hyperandrogenic condition known as Polycystic Ovarian Syndrome as these women are at high risk for developing Non Alcoholic Fatty Liver Disease and early onset liver scarring. Within the transplant setting I also study sex differences in waitlist and post transplant outcomes.

Research Interests

Women with chronic liver disease

Non invasive measures of liver fibrosis

Gender differences in liver transplant outcomes

 

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 106
  1. Clinical cure of chronic hepatitis B is associated with priming and perpetuation of hepatic CD4+ T cell responses.
    Jespersen JM, Avanesyan L, Publicover J, Carey ND, Patel RK, Edwards AW, Stenske S, Shin J, Li J, Simone M, Chew NW, Wong N, Trilok S, Erickson A, Rao A, Loo CP, Stec M, Anderson M, Cloherty G, Sarkar M, Nishimura SL, Combes AJ, Wakil AE, Segal MR, Fragiadakis GK, Cooper SL, Baron JL| | PubMed
  2. Institutional Strategies for Overcoming Academic Bullying, Rising Above Moral Injury, and Achieving Success.
    Paul S, Sarkar M, Rossi AP, Gordon EJ, Brennan DC, Pillai AA| | PubMed
  3. Temporal Trends in Hepatitis C Virus Screening and Management in Pregnant Women and Infants Between 2014 and 2024 in San Francisco, California.
    Betancourt M, Kaur R, Gamez J, Price J, Luetkemeyer A, Seidman D, Sarkar M| | PubMed
  4. Liver cirrhosis among females with cystic fibrosis using hormonal contraception.
    Chin J, Sarkar M, Magaret AS, Hsu C, West N, Walker P, Langfelder-Schwind E, Taylor-Cousar JL, Ladores-Barrett S, Hadijiliadis D, Roe AH, Uluer A, Mody S, Jain R, Dayton LAB, Godfrey EM| | PubMed
  5. Transplant professionals' knowledge, attitudes, and practices related to transgender and gender diverse patient care: A national survey.
    Paul S, Rossi AP, Gordon EJ, Jones J, Balliet W, Coscia L, Katz-Greenberg G, Kumar V, Lee TH, Ravirala R, Shingina A, Targownik LE, Sarkar M| | PubMed
  6. Low anti-Mullerian hormone in reproductive age is associated with MASLD in midlife.
    Cooper KM, Wellons M, Terry JG, Huddleston HG, Cedars MI, Maldonado SS, Sarkar M| | PubMed
  7. Chronic liver disease and hepatology care in transgender and gender diverse populations.
    Nguyen TN, Jackson WE, Roth NC, Cinque F, Sarkar M, Samala N, Lee RS, Strauss AT, Wisocky J, Patel K, Sebastiani G, Streed CG, Lake JE, Lee TH| | PubMed
  8. Contraceptive safety in liver disease: The cost of overstating risk.
    Garriga M, Cedars M, Whetstone S, Sarkar M| | PubMed
  9. Clinical cure of chronic hepatitis B is dependent on activation and perpetuation of robust CD4 + T cell responses.
    Jespersen J JM, Avanesyan L, Publicover J, Carey ND, Patel RK, Edwards AW, Stenske S, Shin J, Li J, Simone M, Chew NW, Wong N, Trilok S, Erickson A, Rao A, Loo CP, Stec M, Anderson M, Cloherty G, Sarkar M, Combes AJ, Wakil AE, Segal MR, Fragiadakis GK, Cooper S, Baron JL| | PubMed
  10. Reproductive health in the liver transplant recipient.
    Dukewich M, Coscia L, Afshar Y, Sarkar M| | PubMed
  11. Health Outcomes in Children of Liver Transplant (LT) Recipients.
    S.L. Maxwell, H. Braun, L.A. Coscia, S. Constantinescu, M. Moritz, M. Sarkar| | UCSF Research Profile
  12. Epidemiologic Trends in Acute, Chronic, and Pregnancy-Specific Liver Diseases in Pregnancy.
    Jutras G, Fenton C, Flemming JA, Gamez J, Irani RA, Kushner T, Yoyo S, Sarkar M| | PubMed
  13. Metabolic dysfunction-associated steatotic liver disease and pregnancy.
    Sarkar M, Kushner T| | PubMed
  14. Sa1525: EPIDEMIOLOGIC TRENDS IN ACUTE, CHRONIC, AND PREGNANCY-SPECIFIC LIVER DISEASES DURING PREGNANCY.
    Gabrielle Jutras, Cynthia Fenton, Tatyana Kushner, Roxanna Irani, Jasmine Gamez, Jennifer A. Flemming, Monika Sarkar| | UCSF Research Profile
  15. Pregnancy After Solid Organ Transplantation: Review of the Evidence and Recommendations.
    Katz-Greenberg G, Afshar Y, Bonn J, Casale J, Constantinescu S, DeFilippis EM, George RP, Iltis A, Jesudason S, Kittleson M, Levine DJ, Moritz MJ, Sarkar M, Shah S, Uccellini K, Coscia LA, Rossi AP, American Society of Transplantation Women’s Health Community of Practice Reproductive Health, Contra| | PubMed
  16. Safety of a trial of labor after cesarean in kidney and liver transplant recipients: A multicenter cohort study.
    Walia A, Yin O, Coscia LA, Constantinescu S, Sarkar M, Moritz MJ, Afshar Y, Irani RA| | PubMed
  17. Outcomes in Female Patients With Chronic Liver Disease Undergoing Infertility Treatment.
    Garriga M, Cedars M, Sarkar M| | PubMed
  18. Family Planning Counseling and Practices in Kidney Transplant Recipients.
    Rajagopal S, Ritchie J, Seidman D, Perito ER, Adey D, Sarkar M| | PubMed
  19. Clinical outcomes in patients with unintended pregnancy after liver transplantation: A multicenter registry cohort study.
    Walia A, Yin O, Coscia L, Afshar Y, Irani R, Constantinescu S, Moritz M, Sarkar M| | PubMed
  20. Unintended Pregnancy After Kidney Transplantation: Risk Factors and Associated Obstetric and Allograft Outcomes.
    Yin O, Gliwa C, Walia A, Coscia L, Constantinescu S, Moritz M, Sarkar M, Irani R, Afshar Y| | PubMed
  21. Contraception in patients with liver disease and liver transplant.
    Garriga M, Zhang G, Sarkar M| | PubMed
  22. How I Approach Hepatocellular Adenomas in Hormonally Distinct Populations: Time to Think Outside the (Contraceptive Pill) Box.
    Wang M, Cedars MI, Mehta N, Sarkar M| | PubMed
  23. Introduction: Pregnancy and liver disease.
    Monika Sarkar| | UCSF Research Profile
  24. Antimullerian Hormone, a Marker of Ovarian Reserve, Is Protective Against Presence and Severity of NASH in Premenopausal Women.
    Maldonado SS, Cedars MI, Yates KP, Wilson LA, Gill R, Terrault NA, Suzuki A, Sarkar MA| | PubMed
  25. Parental leave, childcare policies, and workplace bias for hepatology professionals: A national survey.
    Feld LD, Sarkar M, Au JS, Flemming JA, Gripshover J, Kardashian A, Muir AJ, Nephew L, Orloff SL, Terrault N, Rabinowitz L, Volerman A, Arora V, Farnan J, Villa E| | PubMed
  26. Family planning and donor type: Unrecognized benefits of living donor liver transplantation?
    Sarkar M, Irani RA| | PubMed
  27. Sex differences in chronic liver disease and benign liver lesions.
    Cooper KM, Delk M, Devuni D, Sarkar M| | PubMed
  28. Mo1530 OUTCOMES IN WOMEN WITH CHRONIC LIVER DISEASE UNDERGOING INFERTILITY TREATMENT.
    Meera Garriga, Marcelle I. Cedars, Monika Sarkar| | UCSF Research Profile
  29. Sa1609 POLYCYSTIC OVARY SYNDROME INCREASES FIBROSIS SEVERITY IN YOUNG WOMEN WITH NAFLD.
    Grace Zhang, Marcelle I. Cedars, Heather Huddleston, Sy Han Chiou, Yanin T. Srisengfa, Monika Sarkar| | UCSF Research Profile
  30. Prevalence of nonalcoholic fatty liver disease increased with type 2 diabetes mellitus in overweight/obese youth with polycystic ovary syndrome.
    Patel-Sanchez N, Perito E, Tsai P, Raymond-Flesch M, Lodish M, Sarkar M| | PubMed
  31. Reproductive health and liver disease: a patient-friendly summary of the 2021 AASLD guidance.
    Levy C, Brady CW, Terrault N, Stotts MJ, Sarkar M| | PubMed
  32. Letter to the Editor: Influence of maternal NAFLD on infant weight-the real precursor to NAFLD in offspring?
    Sarkar M, Flemming JA| | PubMed
  33. The key role of hepatology providers in optimizing reproductive care in patients with liver disease: A call to action.
    Kardashian A, Kushner T, Au JS, Flemming JA, Gripshover J, Muir AJ, Orloff SL, Villa E, Sarkar M, AASLD Women’s Initiative Committee| | PubMed
  34. Influence of progestin-only hormonal use on hepatocellular adenomas: A retrospective cohort study.
    Qureshy Z, Lokken RP, Kakar S, Grab J, Mehta N, Sarkar M| | PubMed
  35. Now you see it, now you don't: Estrogen exposure and obesity effects on HCA development and regression.
    Wang M, Sarkar M, Mehta N| | PubMed
  36. Awarding additional MELD points to the shortest waitlist candidates improves sex disparity in access to liver transplant in the United States.
    Bernards S, Lee E, Leung N, Akan M, Gan K, Zhao H, Sarkar M, Tayur S, Mehta N| | PubMed
  37. Polycystic ovary syndrome is associated with nonalcoholic steatohepatitis in women of reproductive age.
    Maldonado SS, Grab J, Wang CW, Huddleston H, Cedars M, Sarkar M| | PubMed
  38. Pregnancy Is Not Associated with an Increased Risk of Decompensation, Transplant, or Death in Compensated Cirrhosis.
    Mullin M, Djerboua M, Sarkar M, Lu J, Velez MP, Brogly S, Terrault NA, Flemming JA| | PubMed
  39. Reply.
    Sarkar M, Irani RA| | PubMed
  40. On the Importance of Safe Access to Reproductive Options for Adolescents and Women With Liver Disease.
    Shingina A, Sarkar M, Feld L| | PubMed
  41. Su1406: POLCYSTIC OVARY SYNDROME (PCOS) INCREASES RISK OF NASH AMONG REPRODUCTIVE-AGED WOMEN WITH NAFLD: A US POPULATION-BASED STUDY.
    Stephanie Maldonado, Joshua Grab, Connie W. Wang, Heather Huddleston, Marcelle I. Cedars, Monika Sarkar| | UCSF Research Profile
  42. Associations of NAFLD with circulating ceramides and impaired glycemia.
    Gadgil MD, Sarkar M, Sands C, Lewis MR, Herrington DM, Kanaya AM| | PubMed
  43. Abstract P139: Changes In Sex Hormones In Premenopausal Black And White Women Associated With Childbearing: The Cardia Women’s Study.
    Sadaf Dabeer, Katherine H Ingram, Duke Appiah, Melissa Wellons, Catherine Kim, Dhananjay Vaidya, David S Siscovick, Cora E Lewis, Charles Quesenberry, Pamela Schreiner, Ronit Calderon-Margalit, Monika Sarkar, Erica P Gunderson| | UCSF Research Profile
  44. Pregnancies With Cirrhosis Are Rising and Associated With Adverse Maternal and Perinatal Outcomes.
    Huang AC, Grab J, Flemming JA, Dodge JL, Irani RA, Sarkar M| | PubMed
  45. Outcomes of pregnancy in autoimmune hepatitis: A population-based study.
    Wang CW, Grab J, Tana MM, Irani RA, Sarkar M| | PubMed
  46. Untangling the Influence of Sex Hormones on Nonalcoholic Fatty Liver Disease in Women.
    Sarkar M, Cedars MI| | PubMed
  47. Pregnancy Outcomes After Living Liver Donation: A Multi-Institutional Study.
    Sonnenberg EM, Lee-Riddle GS, Walls DO, Caicedo JC, Jackson WE, Hughes L, Ladner DP, Liapakis A, Pomfret EA, Sarkar M, Selzner N, Torres AM, Abt PL, Olthoff KM| | PubMed
  48. Sa362 REPRODUCTIVE HEALTH CHARACTERISTICS IN PRE-MENOPAUSAL WOMEN WITH NAFLD.
    Yanin T. Srisengfa, Srilakshmi Seetharaman, Monika Sarkar| | UCSF Research Profile
  49. Relevance of reproductive health to comprehensive hepatology care.
    Rajagopal S, Whetstone S, Sarkar M| | PubMed
  50. Adherence to pregnancy hepatitis B care guidelines in women and infants in the United States and evaluation of two interventions to improve care: A multicentre hospital-based study.
    Kushner T, Kaplowitz E, Mei R, Xu C, Acker A, Rosenbluth E, Oredein I, Sarkar M, Terrault N, Bansal M, Forde KA| | PubMed
  51. NAFLD Cirrhosis Is Rising Among Childbearing Women and Is the Most Common Cause of Cirrhosis in Pregnancy.
    Sarkar M, Djerboua M, Flemming JA| | PubMed
  52. Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases.
    Sarkar M, Brady CW, Fleckenstein J, Forde KA, Khungar V, Molleston JP, Afshar Y, Terrault NA| | PubMed
  53. Reply to: "Intrahepatic cholestasis of pregnancy: An under recognised complication of maternal NAFLD?"
    Sarkar M, Grab J, Irani RA| | PubMed
  54. Testosterone is Associated With Nonalcoholic Steatohepatitis and Fibrosis in Premenopausal Women With NAFLD.
    Sarkar MA, Suzuki A, Abdelmalek MF, Yates KP, Wilson LA, Bass NM, Gill R, Cedars M, Terrault N, NASH Clinical Research Network| | PubMed
  55. Family Planning in Liver Transplant: Patient and Provider Knowledge and Practices.
    Ritchie J, Seidman D, Srisengfa Y, Perito ER, Sarkar M| | PubMed
  56. Outcomes of Pregnant Women With Cirrhosis and Their Infants in a Population-Based Study.
    Flemming JA, Mullin M, Lu J, Sarkar MA, Djerboua M, Velez MP, Brogly S, Terrault NA| | PubMed
  57. SAT147 Increased risk of perinatal complications in women with cirrhosis: a population-based matched cohort study.
    Jacquie Lu, Monika Mullin, Maya Djerboua, Monika Sarkar, Susan Brogly, Maria Velez, Norah Terrault, Jennifer Flemming| | UCSF Research Profile
  58. Reproductive Health and Nonalcoholic Fatty Liver Disease in Women: Considerations Across the Reproductive Lifespan.
    Sarkar M, Suzuki A| | PubMed
  59. Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes.
    Sarkar M, Grab J, Dodge JL, Gunderson EP, Rubin J, Irani RA, Cedars M, Terrault N| | PubMed
  60. Pregnancy in Liver Transplantation.
    Sarkar M, Sawinski D, Coscia L, American Society of Transplantation, Women’s Health Community of Practice| | PubMed
  61. 1004 PREGNANCIES WITH CIRRHOSIS ARE RISING AND ASSOCIATED WITH ADVERSE MATERNAL AND FETAL OUTCOMES.
    Annsa C. Huang, Joshua Grab, Jennifer A. Flemming, Jennifer L. Dodge, Monika Sarkar| | UCSF Research Profile
  62. Shorter Height Is Associated With Lower Probability of Liver Transplantation in Patients With Hepatocellular Carcinoma.
    Lee E, Sarkar M, Dodge J, Kohi M, Mehta N| | PubMed
  63. Low Testosterone Is Associated With Nonalcoholic Steatohepatitis and Fibrosis Severity in Men.
    Sarkar M, Yates K, Suzuki A, Lavine J, Gill R, Ziegler T, Terrault N, Dhindsa S| | PubMed
  64. NAFLD in women: Unique pathways, biomarkers and therapeutic opportunities.
    Yuan L, Kardashian A, Sarkar M| | PubMed
  65. Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis.
    Sarkar M, Terrault N, Chan W, Cedars MI, Huddleston HG, Duwaerts CC, Balitzer D, Gill RM| | PubMed
  66. Deficiencies in Reproductive Health Counseling in Liver Transplant Patients [2H].
    Julia Ritchie, Dominika Seidman, Yanin Srisengfa, Vanessa L. Jacoby, Emily Perito, Monika Sarkar| | UCSF Research Profile
  67. Sa1623 – Low Testosterone is Associated with Nash and Fibrosis Severity in Men with Nafld.
    Monika Sarkar, Katherine P. Yates, Ayako Suzuki, Joel E. Lavine, Ryan M. Gill, Norah Terrault, Sandeep Dhindsa| | UCSF Research Profile
  68. Sex Hormone-Binding Globulin Levels in Young Men Are Associated With Nonalcoholic Fatty Liver Disease in Midlife.
    Sarkar M, VanWagner LB, Terry JG, Carr JJ, Rinella M, Schreiner PJ, Lewis CE, Terrault N, Coronary Artery Risk Development in Young Adults (CARDIA) Cohort| | PubMed
  69. Testosterone Levels in Women: Implications for Fatty Liver and Beyond.
    Sarkar M| | PubMed
  70. Noninvasive Tests for Prognosticating Outcomes in Patients With Chronic Liver Disease in Pregnancy: Ready for Prime Time?
    Kushner T, Sarkar M, Tran T| | PubMed
  71. Sex hormone levels by presence and severity of cirrhosis in women with chronic hepatitis C virus infection.
    Sarkar M, Lai JC, Sawinski D, Zeigler TE, Cedars M, Forde KA| | PubMed
  72. Longer lactation duration is associated with decreased prevalence of non-alcoholic fatty liver disease in women.
    Ajmera VH, Terrault NA, VanWagner LB, Sarkar M, Lewis CE, Carr JJ, Gunderson EP| | PubMed
  73. Chronic Hepatitis B in Pregnancy.
    Kushner T, Sarkar M| | PubMed
  74. Racial and Ethnic Differences in Graft Loss Among Female Liver Transplant Recipients.
    Dave S, Dodge JL, Terrault NA, Sarkar M| | PubMed
  75. Reproductive health in women following abdominal organ transplant.
    Sarkar M, Bramham K, Moritz MJ, Coscia L| | PubMed
  76. The Association of Hispanic Ethnicity with Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome.
    Sarkar M, Terrault N, Duwaerts CC, Tien P, Cedars MI, Huddleston H| | PubMed
  77. Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipient.
    Campos-Varela I, Agudelo EZ, Sarkar M, Roberts JP, Terrault NA| | PubMed
  78. Sex-based disparities in delisting for being "too sick" for liver transplantation.
    Cullaro G, Sarkar M, Lai JC| | PubMed
  79. Acetaminophen-induced Acute Liver Failure Is More Common and More Severe in Women.
    Rubin JB, Hameed B, Gottfried M, Lee WM, Sarkar M, Acute Liver Failure Study Group| | PubMed
  80. Moderate Alcohol Use Is Not Associated With Fibrosis Progression in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Women: A Prospective Cohort Study.
    Kelly EM, Dodge JL, Bacchetti P, Sarkar M, French AL, Tien PC, Glesby MJ, Golub ET, Augenbraun M, Plankey M, Peters MG| | PubMed
  81. Perinatal programming of adolescent nonalcoholic fatty liver disease: A case for gender inequality?
    Sarkar M, Baffy G| | PubMed
  82. Reproductive Aging and Hepatic Fibrosis Progression in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Women.
    Sarkar M, Dodge JL, Greenblatt RM, Kuniholm MH, DeHovitz J, Plankey M, Kovacs A, French AL, Seaberg EC, Ofotokun I, Fischl M, Overton E, Kelly E, Bacchetti P, Peters MG, Women’s Interagency HIV Study| | PubMed
  83. Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife.
    Sarkar M, Wellons M, Cedars MI, VanWagner L, Gunderson EP, Ajmera V, Torchen L, Siscovick D, Carr JJ, Terry JG, Rinella M, Lewis CE, Terrault N| | PubMed
  84. Aggressive non-alcoholic steatohepatitis following rapid weight loss and/or malnutrition.
    Tsai JH, Ferrell LD, Tan V, Yeh MM, Sarkar M, Gill RM| | PubMed
  85. Sex differences in the association of HIV infection with hepatic steatosis.
    Kardashian A, Ma Y, Scherzer R, Price JC, Sarkar M, Korn N, Tillinghast K, Peters MG, Noworolski SM, Tien PC| | PubMed
  86. Increased hepatocellular carcinoma recurrence in women compared to men with high alpha fetoprotein at liver transplant.
    Sarkar M, Dodge JL, Roberts JP, Terrault N, Yao F, Mehta N| | PubMed
  87. Association of Hepatitis C Virus Infection With CD4/CD8 Ratio in HIV-Positive Women.
    Kuniholm MH, O'Brien TR, Prokunina-Olsson L, Augenbraun M, Plankey M, Karim R, Sarkar M, French AL, Pierce C, Strickler HD, Anastos K| | PubMed
  88. Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in HIV/Hepatitis C Virus-coinfected Women.
    Kelly EM, Dodge JL, Sarkar M, French AL, Tien PC, Glesby MJ, Golub ET, Augenbraun M, Plankey M, Peters MG| | PubMed
  89. 352 Sex Differences in Acetaminophen-Induced Acute Liver Injury and Acute Liver Failure.
    Jessica Rubin, Bilal Hameed, Michelle Gottfried, William M. Lee, Monika Sarkar| | UCSF Research Profile
  90. Association between markers of non-alcoholic fatty liver disease and glucose tolerance in polycystic ovarian syndrome population.
    Asima K. Ahmad, Chia-Ning Kao, Monika Sarkar, Marcelle I. Cedars, Heather Huddleston| | UCSF Research Profile
  91. Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing.
    Mehta N, Sarkar M, Dodge JL, Fidelman N, Roberts JP, Yao FY| | PubMed
  92. PS073 Light to Moderate Alcohol Use is not Associated with Long-Term Progression of Liver Fibrosis in Hiv Hcv Coinfected Women.
    E.M. Kelly, J. Dodge, P. Bacchetti, M. Sarkar, A. French, P. Tien, M. Glesby, E. Golub, M. Augenbraun, M. Plankey, M. Peters| | UCSF Research Profile
  93. PS077 Sex Differences in Acetaminophen-Induced Acute Liver Injury and Acute Liver Failure.
    J. Rubin, B. Hameed, M. Gottfried, W. Lee, M. Sarkar, the Acute Liver Failure Study Group| | UCSF Research Profile
  94. Association of IFNL3 and IFNL4 polymorphisms with liver-related mortality in a multiracial cohort of HIV/HCV-coinfected women.
    Sarkar M, Aouzierat B, Bacchetti P, Prokunina-Olsson L, French A, Seaberg E, O'Brien TR, Kuniholm MH, Minkoff H, Plankey M, Strickler HD, Peters MG, Women's Interagency HIV| | PubMed
  95. Outcomes in liver transplantation: does sex matter?
    Sarkar M, Watt KD, Terrault N, Berenguer M| | PubMed
  96. Ending vertical transmission of hepatitis B: the third trimester intervention.
    Sarkar M, Terrault NA| | PubMed
  97. Characteristics and management of patients with chronic hepatitis B in an integrated care setting.
    Sarkar M, Shvachko VA, Ready JB, Pauly MP, Terrault NA, Peters MG, Manos MM| | PubMed
  98. Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinoma.
    Mehta N, Fidelman N, Sarkar M, Yao FY| | PubMed
  99. Racial/ethnic differences in spontaneous HCV clearance in HIV infected and uninfected women.
    Sarkar M, Bacchetti P, Tien P, Mileti E, French AL, Edlin BR, Keller M, Seaberg E, Nowicki MJ, Young M, Peters MG| | PubMed
  100. Lower liver-related death in African-American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women.
    Sarkar M, Bacchetti P, French AL, Tien P, Glesby MJ, Nowicki M, Plankey M, Gange S, Sharp G, Minkoff H, Peters MG, Women's Interagency HIV Study (WIHS)| | PubMed
  101. 466 Hepatitis B Treatment in a California Managed Care Population: A Retrospective Analysis of Treatment and Monitoring Practices.
    Monika Sarkar, Valentina Shvachko, Marion G. Peters, Michele Manos| | UCSF Research Profile
  102. Hepatocellular carcinoma screening practices and impact on survival among hepatitis B-infected Asian Americans.
    Sarkar M, Stewart S, Yu A, Chen MS, Nguyen TT, Khalili M| | PubMed
  103. Chapter 32 Hepatitis virus infections.
    Marion G. Peters, Monika Sarkar| | UCSF Research Profile
  104. Proton-pump inhibitor use and the risk for community-acquired pneumonia.
    Sarkar M, Hennessy S, Yang YX| | PubMed
  105. Chronic statin therapy and the risk of colorectal cancer.
    Yang YX, Hennessy S, Propert K, Hwang WT, Sarkar M, Lewis JD| | PubMed
  106. Presentation and management of acute fistulization of a foregut duplication cyst.
    Sarkar M, Wood R, Oh Y, Hecht TE, Kaiser L, Wasserstein A, Kochman ML| | PubMed